Search

A Phase 2/3 Study of TVP-1012 at 0.5 mg or 1 mg in Levodopa Treated Parkinson's Disease Participants

Trial Phase 2 Completed March 1, 2022

Safety and Efficacy of Droxidopa for Fatigue in Patients With Parkinsonism

Trial Phase 2 Withdrawn March 1, 2022

A Long-term, Phase 3 Study of TVP-1012 (1 mg) in Levodopa Treated Parkinson's Disease Participants

Trial Phase 3 Completed March 1, 2022

A Phase 3, Long-term, Extension Study of TVP-1012 (1 mg) in Early Parkinson's Disease Participants

Trial Phase 3 Completed March 1, 2022

A Phase 3 Study of TVP-1012 (1 mg) in Early Parkinson's Disease Patients

Trial Phase 3 Completed March 1, 2022

Evaluating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of BIIB054 in Participants With Parkinson's Disease

Trial Phase 2 Terminated Feb. 27, 2022

Cognitive-driven ADL Impairment as a Predictor for PDD

Trial N/A Completed Feb. 23, 2022

Investigation of Gait, Foot Pressure Distribution and Balance in Parkinson's Patients With Motor Freezing

Trial N/A Completed Feb. 21, 2022

Assessment of Fluctuating Parkinson's Disease With Sensor-based Home Monitoring

Trial N/A Completed Feb. 17, 2022

Compensation Mechanisms in Parkinson's Disease

Trial N/A Completed Feb. 17, 2022

Systematic Follow up of Second Line Treatments for Parkinson's Disease (Deep Brain Stimulation, Apomorphin Pump, Duodopa Pump)

Trial N/A Not yet recruiting Feb. 16, 2022

Efficacy and Safety of Amantadine Hydrochloride (HCl) ER Tablets to Treat Parkinson's Disease Patients With LID.

Trial Phase 3 Terminated Feb. 15, 2022

Efficacy and Safety of Amantadine Hydrogen Chloride (HCl) ER Tablets in Parkinson's Disease Subjects With LID

Trial Phase 3 Terminated Feb. 15, 2022

Incentive Spirometer and Inspiratory Muscle Trainer

Trial N/A Completed Feb. 9, 2022

DTI in Evaluation of Parkinsons Disease

Trial N/A Unknown Feb. 8, 2022

Spine MRI in Patients With Deep Brain Stimulation (DBS)

Trial N/A Completed Feb. 8, 2022

Utilization of Target Ranges to Treat Parkinson's Disease With the PKG

Trial N/A Terminated Feb. 7, 2022

Multi-limb Dual-task Control in Parkinson's Disease

Trial N/A Completed Feb. 6, 2022

Adaptive Closed Loop Neuromodulation and Neural Signatures of Parkinson's Disease

Trial N/A Completed Jan. 31, 2022

Movement Disorders and Early Maladaptive Schemas

Trial N/A Completed Jan. 30, 2022